Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,229,423
-$9,346,915 QoQ
Shares Held
2,842,892
-6.5% QoQ
Ownership
1.91%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026First Light Asset Management, LLC holds $433,143,975 across 15 Biotechnology names. MDXG ranks #11 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PVLA |
Palvella Therapeutics, Inc.
|
980,758 | $122,251,484 | |
| 2 | CNTA |
Centessa Pharmaceuticals plc
|
1,560,991 | $62,002,562 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
576,684 | $48,539,492 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
1,089,670 | $39,576,814 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,001,846 | $31,558,149 | |
| 6 | ANAB |
Anaptysbio, Inc
|
565,431 | $20,905,849 | |
| 7 | TECX |
Tectonic Therapeutic, Inc.
|
647,743 | $20,021,736 | |
| 8 | SEPN |
Septerna, Inc.
|
732,860 | $17,610,625 |
All Filings in MDXG
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,229,423 | 2,842,892 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,576,338 | 3,039,341 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $25,497,604 | 3,652,952 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,776,988 | 1,927,494 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,243,362 | 3,453,074 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,167,942 | 3,343,861 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||